PRPH
Price:
$0.08
Market Cap:
$378.96K
ProPhase Labs, Inc., founded in 1989 in Garden City, New York (and previously known as The Quigley Corporation), operates as a diversified company with two main areas of focus: Consumer Products and Diagnostic Services. Through its Consumer Products division, ProPhase Labs is actively involved in the entire process—from researching and developing to manufacturing, distributing, marketing, and selling—a range of over-the-counter (OTC) healthcare items and nutritional supplements within the United States. Notable offerings include dietary supplements like Legendz XL, which supports male sexual health, and Triple Edge XL, formulated to enhance energy and stamina. The Diagnostic Services segment...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1994-04-04
Stock Exchange
NASDAQ
Ticker
PRPH
According to ProPhase Labs, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.03. This represents a change of -90.42% compared to the average of -0.31 of the last 4 quarters.
The mean historical PE Ratio of ProPhase Labs, Inc. over the last ten years is -9.19. The current -0.03 PE Ratio has changed -67.37% with respect to the historical average. Over the past ten years (40 quarters), PRPH's PE Ratio was at its highest in in the March 2018 quarter at 379.49. The PE Ratio was at its lowest in in the June 2018 quarter at -70.96.
Average
-9.19
Median
-1.30
Minimum
-42.00
Maximum
8.76
Discovering the peaks and valleys of ProPhase Labs, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 72.55%
Maximum Annual PE Ratio = 8.76
Minimum Annual Increase = -2625.81%
Minimum Annual PE Ratio = -42.00
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -0.26 | -10.83% |
| 2024 | -0.29 | -87.42% |
| 2023 | -2.31 | -155.98% |
| 2022 | 4.12 | -52.95% |
| 2021 | 8.76 | -138.15% |
| 2020 | -22.95 | 51.45% |
| 2019 | -15.15 | -63.92% |
| 2018 | -42.00 | -2625.81% |
| 2017 | 1.66 | -107.07% |
| 2016 | -23.53 | 72.55% |
The current PE Ratio of ProPhase Labs, Inc. (PRPH) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.95
5-year avg
2.00
10-year avg
-9.19
ProPhase Labs, Inc.’s PE Ratio is greater than Aytu BioPharma, Inc. (-0.54), less than TherapeuticsMD, Inc. (126.62), greater than Allurion Technologies Inc. (-0.13), greater than Ernexa Therapeutics Inc. (-0.20), greater than Biofrontera Inc. (-0.88), greater than Adaptimmune Therapeutics plc (-0.07), greater than Aethlon Medical, Inc. (-0.12), greater than Co-Diagnostics, Inc. (-0.10), greater than Lunai Bioworks Inc. (-0.06), less than Sunshine Biopharma, Inc. (-0.02),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.54 | $18.71M | |
| 126.62 | $22.57M | |
| -0.13 | $7.48M | |
| -0.20 | $1.95M | |
| -0.88 | $12.64M | |
| -0.07 | $75.16M | |
| -0.12 | $1.44M | |
| -0.10 | $3.76M | |
| -0.06 | $17.14M | |
| -0.02 | $1.07M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ProPhase Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ProPhase Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is ProPhase Labs, Inc.'s PE Ratio?
How is the PE Ratio calculated for ProPhase Labs, Inc. (PRPH)?
What is the highest PE Ratio for ProPhase Labs, Inc. (PRPH)?
What is the 3-year average PE Ratio for ProPhase Labs, Inc. (PRPH)?
What is the 5-year average PE Ratio for ProPhase Labs, Inc. (PRPH)?
How does the current PE Ratio for ProPhase Labs, Inc. (PRPH) compare to its historical average?